Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) – final report To determine long-term immunogenicity and reactogenicity of different SARS-CoV-2 mRNA-vaccines in a population ≥75 years in a randomized trial.Partici…

Final EU-COVAT-1-AGED results:
Randomized 1st & 2nd mRNA booster trial in adults ≥75 yrs. Full-dose mRNA-1273 showed higher anti-RBD IgG & neutralization vs BNT162b2. Neutralization declined vs all 25 variants at 12 months.
www.sciencedirect.com/science/arti...
#COVID19 #Vaccines #Aging #VACCELERATE

EU-funded VACCELERATE Project concludes with positive assessment An independent expert review commissioned by the Health and Digital Executive Agency (HaDEA) confirms that the four-year project coordinated in Cologne has made a successful contribution to preparing ...

EU-funded #VACCELERATE has successfully concluded with a positive expert review: www.uni-koeln.de/en/universit... Proud of our Europe-wide network, volunteer registry & training that will strengthen future vaccine research and pandemic preparedness. Onwards! 🚀#pandemicpreparedness #EUresearch

PRIOH-1 | Herpes-simplex-Virus | Erfahren Sie mehr Wenn Sie ein geschwächtes Immunsystem haben und aufgrund des Herpes-simplex-Virus an Läsionen leiden, prüfen Sie, ob Sie für die PRIOH-1-Studie infrage kommen.

Das #VACCELERATE Freiwilligenregister sucht Teilnehmende für eine klinische Studie zu einem noch nicht zugelassenen Medikament für die Behandlung von #Herpes. https://www.hsvclinicaltrial.com/german-de/home---de

PRIOH-1 | Herpes-simplex-Virus | Erfahren Sie mehr Wenn Sie ein geschwächtes Immunsystem haben und aufgrund des Herpes-simplex-Virus an Läsionen leiden, prüfen Sie, ob Sie für die PRIOH-1-Studie infrage kommen.

Das #VACCELERATE Freiwilligenregister sucht Teilnehmende für eine klinische Studie zu einem noch nicht zugelassenen Medikament für die Behandlung von #Herpes. www.hsvclinicaltrial.com/german-de/ho...

📈 MAK-5-50+ Week 19: Only one SARS-CoV-2 case reported, no detections of #Influenza A/B virus, #RSV or #ADV. Respiratory virus activity remains low. Find out more: vaccelerate.eu/mak-5-50/ #MAK550Plus #COVID19 #RespiratoryViruses #VACCELERATE

📊 Poll result from our recent VACCELERATE webinar on data interoperability in COVID-19 vaccine trials:
50% of participants say ethics & consent structure is the most critical aspect for successful data sharing, followed by data collection procedures (30%). #VACCELERATE #ClinicalResearch

📢 The final VACCELERATE webinar is now online! 🎥 Dive into insights on data interoperability in COVID-19 vaccine trials. Don’t miss this session with top experts.
Watch now 👉 www.youtube.com/watch?v=blFe... #VACCELERATE #ClinicalResearch #COVID19 @ecrin.bsky.social

📢 Don’t miss our upcoming VACCELERATE webinar: How can data standards boost COVID-19 vaccine trial efficiency?
🗓️ May 13 | 10:00–11:00 CEST
✅ Now EACCME®-accredited (1 CME credit)!
📌 Register: uni-koeln.zoom.us/meeting/regi...
#VACCELERATE #CME #COVID19 #ClinicalTrials

Proud to have represented at ESCMID Global 2025 with 15 posters, 8 talks & 14 dedicated team members!
A big thank you to everyone who shared insights, connected, and contributed to advancing infectious disease research.
#ESCMIDGlobal #InfectiousDiseases #VACCELERATE

🌐 How can data standards boost COVID-19 vaccine trial efficiency?
Join our VACCELERATE webinar on May 13 (10:00–11:00 CEST) – now EACCME®-accredited with 1 CME credit!
📌 Register: uni-koeln.zoom.us/meeting/regi... #VACCELERATE #CME #ClinicalTrials #COVID19
@ecrin.bsky.social

🌐 How can data standards boost COVID-19 vaccine trial efficiency?
Find out on May 13, 2025 (10:00–11:00 CEST) at our VACCELERATE webinar on Data Interoperability in Clinical Trials!
📌 Register now: uni-koeln.zoom.us/meeting/regi...
#VACCELERATE #ClinicalTrials #COVID19 @ecrin.bsky.social

🚀 Join us on May 13, 2025 (10:00-11:00 CEST) for an insightful webinar on Data Interoperability in COVID-19 Vaccine Trials! Experts from VACCELERATE will discuss how data standards enhance trial efficiency. Don't miss it!
Register now: uni-koeln.zoom.us/meeting/regi...! #ClinicalTrials #VACCELERATE

📊 New graph update for the MAK5-50+ study! Last week, 1 Flu A and 1 ADV case were detected. Stay informed about the latest findings and explore more details here: vaccelerate.eu/mak-5-50/ 🔬 #MAK550 #FluA #ADV #Research #VACCELERATE

🚨 Final #VACCELERATE Webinar! 🚨
Join us on May 13, 2025 (10:00-11:00 CEST) for our last webinar: 📌 Data Interoperability in #COVID19 Vaccine Trials
Experts will share key insights on data standards & interoperability. Don’t miss it!
🔗 Register now: uni-koeln.zoom.us/meeting/regi... #ClinicalTrials

Wir kehren Corona unter den Teppich – ein Fehler, der uns einholt? Nach Corona kommen weitere Pandemien, sagen Fachleute. Um sich auf künftige Krisen vorzubereiten, sei es wichtig, alte zu verstehen. Doch genau daran hakt es in Deutschland. Lohnt die Aufarbeitung noc...

Wie lernen wir aus Corona? 🦠🔬 Fachleute betonen die Bedeutung der Vorbereitung auf künftige Pandemien: www.rnd.de/gesundheit/w....
#VACCELERATE beschleunigt klinische Studien – ein wichtiger Beitrag zur #PandemicPreparedness.
Volunteer Registry: v-reg.eu
Site Network: vaccelerate.eu/site-network/

4. Nationale Konferenz „Patienten als Partner der Krebsforschung" Die Beteiligung von Patient:innen an der Krebsforschung gewinnt zunehmend an Bedeutung – und gemeinsam gestalten wir diesen Wandel aktiv mit! Deshalb laden wir Sie herzlich zur 4. Nationalen Konferenz...

🧬 Die 4. Nationale Konferenz „Patienten als Partner der Krebsforschung” (26.–28.09.2025, Berlin) widmet sich dem Thema KI in der Krebsforschung. Mehr Infos: indico.dkfz.de/event/1124/

Forschung unterstützen? Jetzt im #VACCELERATE Freiwilligenregister anmelden: v-reg.eu 💙 #Forschung #KI

📢 Latest MAK5-50+ Study Update! 🦠📊
In week 11, we detected 1 Flu A 🏥 and 1 ADV 🧬 case. Stay informed about respiratory virus trends!
📍 More details here: vaccelerate.eu/mak-5-50/
#MAK550+ #FluA #Adenovirus #PublicHealth #VACCELERATE

OB, Museumsleiter, Arena-Chef: Fünf Jahre Corona - So haben wir den Lockdown in Köln erlebt Wie war der erste Lockdown? Und was ist uns von Corona geblieben? Wir haben Menschen aus der Stadtgesellschaft befragt.

Vor 5 Jahren: Lockdown in Köln. Heute: Dank #VACCELERATE sind wir besser vorbereitet! 💪 Mit #VolunteerRegistry & #SiteNetwork können Impfstudien schneller starten – ein Gamechanger für die nächste Pandemie. 🔬🚀 #Forschung #Pandemievorsorge www.rundschau-online.de/koeln/fuenf-...

VACCELERATE

📅 5 years ago, the WHO declared COVID-19 a pandemic. This anniversary reminds us: Research & preparedness matter! 💉 #VACCELERATE continues to advance clinical trials for faster vaccine development through its Volunteer Registry & Site Network. Join us in shaping the future: vaccelerate.eu #COVID19

Data Interoperability in COVID-19 Vaccine Trials: Methodological Approach in the VACCELERATE Project Data standards are not only key to making data processing efficient but also fundamental to ensuring data interoperability. When clinical trial data a…

Boosting #DataInteroperability in #COVID19 vaccine trials! 🏥📊 The #VACCELERATE project shows how standardized clinical trial data improve efficiency, analysis & secure exchange. A unified approach = better research! 🔬💡 Read more: www.sciencedirect.com/org/science/... #ClinicalTrials #HealthTech

Join the #VACCELERATE #SiteNetwork! 🚀 A Europe-wide platform connecting clinical trial sites & volunteers to accelerate research. Let's work together for a healthier future! 🏥🔬
More information: vaccelerate.eu/site-network/
#ClinicalTrials #Research

Latest results from the MAK5-50+ study: #FluA cases are at 2, while #COVID19 cases stand at 1. A closer look at the trends of the #FluSeason. Stay informed and follow updates at vaccelerate.eu/mak-5-50/.
#FluA #MAK550 #Influenza #RSV #VACCELERATE #PublicHealth

🎥 Watch the recording of the #VACCELERATE webinar on Long COVID clinical trials with @scheibenbogen.bsky.social from 2023! 🧬 Gain insights into research challenges and ongoing studies. 📚
📺 Watch here: www.youtube.com/watch?v=fATa...
#LongCOVID #ClinicalTrials #Research

Last week's #MAK5-50+ results:
🦠 #Influenza A: 7
🦠 Influenza B: 4
🦠 #COVID19: 3
🦠 #RSV: 2
#Flu A leads, but multiple #viruses detected. Stay vigilant & take precautions.
Updates: vaccelerate.eu/mak-5-50/
#PublicHealth #VACCELERATE #ClinicalResearch #VirusTracking

Corona in Köln und der Welt Aktuelle Top-News zu Ob Corona-Zahlen, Corona-Regeln oder Corona-Symptome: Wir informieren Sie umfassend und tagesaktuell zu allen Themen. finden Sie hier bei Kölner Stadt-Anzeiger - aktuelle Nachrich...

www.ksta.de/themen/corona During #COVID19, #VACCELERATE -coordinated at the University Hospital Cologne- played a crucial role in accelerating (#vaccine) #studies. By streamlining research, we’re now better prepared for future #pandemics. Collaboration saves lives! 💉🌍 #ResearchMatters

Last week’s data shows a continued decline in #SARSCoV2 cases, with only a few positives for other #respiratory #viruses. Two #Influenza cases were detected—we’re curious to see if numbers rise soon. Stay vigilant! Updates: vaccelerate.eu/mak-5-50/ #PublicHealth #VACCELERATE #ClinicalResearch

Today marks the final day of #EUfunding for #VACCELERATE. A heartfelt thank you to everyone who advanced (#vaccine) #research across #EU. The great infrastructure we built will remain for future collaboration #VolunteerRegistry #SiteNetwork #StudyNurseCourse. Together, we make a difference!

Homepage - en - v-reg.eu Yes, I dowant the best research! Clinical trials are our investment in the future! With our research, we study diseases and hope to save many lives. Our studies are diverse and range from studies usin...

Looking to make a difference? Join the #VACCELERATE #VolunteerRegistry today: v-reg.eu/en/! Help accelerate the fight against global health challenges and support #research efforts. #Volunteer #GlobalHealth #ClinicalTrials

Today, the #VACCELERATE Showcase Event highlighted four years of achievements in EU #vaccine #research! Missed it? Watch the recording and discover how we accelerated #clinicaltrials and built a strong network for the future: www.youtube.com/watch?v=wf_H... #VACCELERATE #VaccineResearch

Exciting discussions, inspiring talks, and valuable insights! Today marked the #VACCELERATE Annual Meeting, celebrating milestones in clinical trial networks and #volunteer engagement. Thank you to all contributors for driving innovation in (#vaccine) #research! #ClinicalTrials